» Articles » PMID: 33766508

Highly Multiplexed Mass Cytometry Identifies the Immunophenotype in the Skin of Dermatomyositis

Overview
Publisher Elsevier
Specialty Dermatology
Date 2021 Mar 26
PMID 33766508
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Dermatomyositis (DM) is a rare, systemic autoimmune disease that most frequently affects the skin, muscles, and lungs. The inflammatory infiltrate in the skin has not been fully characterized, and, in this study, we took a single-cell, unbiased approach using imaging mass cytometry. Substantial monocyte‒macrophage diversity was observed, with the CD14+ population correlating positively with Cutaneous Dermatomyositis Disease Area and Severity Index scores (P = 0.031). The T-cell compartment revealed CD4+ T, CD8+ T, and FOXP3+ T cells. Activated (CD69+) circulating memory T cells correlated positively with Cutaneous Dermatomyositis Disease Area and Severity Index scores (P = 0.0268). IFN-β protein was highly upregulated in the T-cell, macrophage, dendritic cell, and endothelial cell populations of DM skin. Myeloid dendritic cells expressed phosphorylated peroxisome proliferator‒activated receptor γ, phosphorylated IRF3, IL-4, and IL-31, and their quantity correlated with itch as measured in Skindex-29. Plasmacytoid dendritic cells colocalized with IFN-γ in addition to the known colocalization with IFN-β. Nuclear phosphorylated peroxisome proliferator‒activated receptor γ expression was found in the DM endothelium. Imaging mass cytometry allows us to characterize single cells in the immune cell population and identify upregulated cytokines and inflammatory pathways in DM. These findings have important implications for the development of future targeted therapies for DM.

Citing Articles

Mass cytometry: exploring the immune landscape of systemic autoimmune and inflammatory diseases in the past fourteen years.

Kante A, Chevalier M, Sene D, Chauffier J, Mouly S, Chousterman B Front Immunol. 2025; 15:1509782.

PMID: 39896815 PMC: 11782038. DOI: 10.3389/fimmu.2024.1509782.


Long-Term Safety and Efficacy of Lenabasum, a Cannabinoid Receptor Type 2 Agonist, in Patients with Dermatomyositis with Refractory Skin Disease: Follow-Up Data from a 3-Year Open-Label Extension Study.

Stone C, Ahuja G, Lopes Almeida Gomes L, Poroye J, Faden D, Xie L JID Innov. 2024; 5(1):100311.

PMID: 39403556 PMC: 11472610. DOI: 10.1016/j.xjidi.2024.100311.


Understanding the Role of Type I Interferons in Cutaneous Lupus and Dermatomyositis: Toward Better Therapeutics.

Hile G, Werth V Arthritis Rheumatol. 2024; 77(1):1-11.

PMID: 39262215 PMC: 11685000. DOI: 10.1002/art.42983.


Single-cell mass cytometry in immunological skin diseases.

Zhao M, Cheng Y, Gao J, Zhou F Front Immunol. 2024; 15:1401102.

PMID: 39081313 PMC: 11286489. DOI: 10.3389/fimmu.2024.1401102.


Herbal supplement Spirulina stimulates inflammatory cytokine production in patients with dermatomyositis .

Bax C, Diaz D, Li Y, Vazquez T, Patel J, Grinnell M iScience. 2023; 26(11):108355.

PMID: 38026219 PMC: 10665953. DOI: 10.1016/j.isci.2023.108355.


References
1.
Osborn J, Hobbs S, Mooster J, Khan T, Kilgore A, Harbour J . Central memory CD8+ T cells become CD69+ tissue-residents during viral skin infection independent of CD62L-mediated lymph node surveillance. PLoS Pathog. 2019; 15(3):e1007633. PMC: 6420010. DOI: 10.1371/journal.ppat.1007633. View

2.
Marx N, Mach F, Sauty A, Leung J, Sarafi M, Ransohoff R . Peroxisome proliferator-activated receptor-gamma activators inhibit IFN-gamma-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells. J Immunol. 2000; 164(12):6503-8. PMC: 4231715. DOI: 10.4049/jimmunol.164.12.6503. View

3.
Psarras A, Alase A, Antanaviciute A, Carr I, Md Yusof M, Wittmann M . Functionally impaired plasmacytoid dendritic cells and non-haematopoietic sources of type I interferon characterize human autoimmunity. Nat Commun. 2020; 11(1):6149. PMC: 7708979. DOI: 10.1038/s41467-020-19918-z. View

4.
Lee A, Ashkar A . The Dual Nature of Type I and Type II Interferons. Front Immunol. 2018; 9:2061. PMC: 6141705. DOI: 10.3389/fimmu.2018.02061. View

5.
Nencioni A, Grunebach F, Zobywlaski A, Denzlinger C, Brugger W, Brossart P . Dendritic cell immunogenicity is regulated by peroxisome proliferator-activated receptor gamma. J Immunol. 2002; 169(3):1228-35. DOI: 10.4049/jimmunol.169.3.1228. View